当前位置： SCI文献检索 > ENDOCRINE-RELATED CANCER期刊下所有文献 > 15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma.

15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma.

Abstract：

:Although anatomic imaging to assess the precise localization of pheochromocytomas/paragangliomas (PHEOs/PGLs) is unavoidable before any surgical intervention on these tumors, functional imaging is becoming an inseparable portion of the imaging algorithm for these tumors. This review article presents applications of the most up-to-date functional imaging modalities and image-based treatment to PHEOs/PGLs patients. Functional imaging techniques provide whole-body localization (number of tumors present along with metastatic deposits) together with genetic-specific imaging approaches to PHEOs/PGLs, thus enabling highly specific and sensitive PHEO/PGL detection and delineation that now greatly impact the management of patients. Radionuclide imaging techniques also play a crucial role in the prediction of possible radioactive treatment options for PHEO/PGL. In contrast to previous imaging algorithms used for either assessement of these patients or their follow-up, endocrinologists, surgeons, oncologists, pediatricians, and other specialists require functional imaging before any therapeutic plan is outlined to the patient, and follow-up, especially in patients with metastatic disease, is based on the periodic use of functional imaging, often reducing or substituting for anatomical imaging. In similar specific indications, this will be further powered by using PET/MR in the assessment of these tumors. In the near future, it is expected that PHEO/PGL patients will benefit even more from an assessement of the functional characteristics of these tumors and new imaging-based treatment options. Finally, due to the use of new targeting moieties, gene-targeted radiotherapeutics and nanobodies-based theranostic approaches are expected to become a reality in the near future.

journal_name

Endocr Relat Cancer

journal_title

Endocrine-related cancer

authors

Castinetti F,Kroiss A,Kumar R,Pacak K,Taieb D

doi

10.1530/ERC-15-0175

subject

Has Abstract

pub_date

2015-08-01 00:00:00

pages

T135-45

issue

4

eissn

1351-0088

issn

1479-6821

pii

ERC-15-0175

journal_volume

22

pub_type

杂志文章,评审

相关文献

ENDOCRINE-RELATED CANCER文献大全
  • Management of carcinoid syndrome: a systematic review and meta-analysis.

    abstract：:Carcinoid syndrome (CS) is a debilitating disease caused by functional neuroendocrine tumors. Several treatment options are available to alleviate the hormonal symptoms, but their relative efficacy is unknown. Online databases were searched for publications on the treatment of CS symptoms. Independent reviewers assess...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,meta分析

    doi：10.1530/ERC-18-0495

    authors： Hofland J,Herrera-Martínez AD,Zandee WT,de Herder WW

    更新日期：2019-03-01 00:00:00

  • Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer.

    abstract：:The aim of this systematic review is to study the features of cribriform-morular variant of papillary thyroid carcinoma (CMV-PTC) by analysing the 129 documented cases in the English literature. The disease occurred almost exclusively in women. The median age of presentation for CMV-PTC was 24 years. Slightly over hal...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-17-0014

    authors： Lam AK,Saremi N

    更新日期：2017-04-01 00:00:00

  • CD74 expression and its therapeutic potential in thyroid carcinoma.

    abstract：:CD74, the invariant chain of major histocompatibility complex class II, is also a receptor for macrophage migration inhibitory factor (MIF). CD74 and MIF have been associated with tumor progression and metastasis in hematologic and solid tumors. In this study, we found that 60 and 65% of papillary thyroid cancers were...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-14-0269

    authors： Cheng SP,Liu CL,Chen MJ,Chien MN,Leung CH,Lin CH,Hsu YC,Lee JJ

    更新日期：2015-04-01 00:00:00

  • Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.

    abstract：:Malignant growth of small-cell lung carcinoma is promoted by various neuroendocrine autocrine/paracrine loops. Therefore, to interfere with this mitogenic process, it is crucial to elucidate the mechanisms involved. It is known that the oxytocin (OT) and vasopressin (VP) genes, normally transcriptionally restricted in...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1677/erc.1.00803

    authors： Péqueux C,Keegan BP,Hagelstein MT,Geenen V,Legros JJ,North WG

    更新日期：2004-12-01 00:00:00

  • Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.

    abstract：:The expression of estrogen receptor α (ERα) in breast cancer identifies patients most likely to respond to endocrine treatment. The second ER, ERβ, is also expressed in breast tumors, but its function and therapeutic potential need further study. Although in vitro studies have established that ERβ opposes transcriptio...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-13-0444

    authors： Jonsson P,Katchy A,Williams C

    更新日期：2014-01-30 00:00:00

  • Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies.

    abstract：:Oestrogen receptors (ESRs) regulate the growth and differentiation of normal ovarian epithelia. However, to date their role as biomarkers in the clinical setting of ovarian cancer remains unclear. In view of potential endocrine treatment options, we tested the role of ESR1 mRNA expression in ovarian cancer in the cont...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1677/ERC-08-0342

    authors： Zamagni C,Wirtz RM,De Iaco P,Rosati M,Veltrup E,Rosati F,Capizzi E,Cacciari N,Alboni C,Bernardi A,Massari F,Quercia S,D'Errico Grigioni A,Dietel M,Sehouli J,Denkert C,Martoni AA

    更新日期：2009-12-01 00:00:00

  • Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer.

    abstract：:Vandetanib is an oral tyrosine kinase inhibitor approved for treatment of advanced symptomatic or progressive medullary thyroid cancer (MTC). The current study (Nbib1496313) evaluated the benefit-risk of two starting doses of vandetanib in patients with symptomatic or progressive MTC. Patients were randomized 1:1 to r...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1530/ERC-18-0258

    authors： Hu MI,Elisei R,Dedecjus M,Popovtzer A,Druce M,Kapiteijn E,Pacini F,Locati L,Krajewska J,Weiss R,Gagel RF

    更新日期：2019-02-01 00:00:00

  • Rationale for the development of alternative forms of androgen deprivation therapy.

    abstract：:With few exceptions, the almost 30,000 prostate cancer deaths annually in the United States are due to failure of androgen deprivation therapy. Androgen deprivation therapy prevents ligand-activation of the androgen receptor. Despite initial remission after androgen deprivation therapy, prostate cancer almost invariab...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-17-0121

    authors： Kumari S,Senapati D,Heemers HV

    更新日期：2017-08-01 00:00:00

  • Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.

    abstract：:Thyroid cancer is rare, but it is the most frequent endocrine malignancy. Its prognosis is generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such as papillary and follicular cancers, which have survival rates of approximately 95% at 40 years. However, 15-20% of cases became radioi...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-15-0555

    authors： Viola D,Valerio L,Molinaro E,Agate L,Bottici V,Biagini A,Lorusso L,Cappagli V,Pieruzzi L,Giani C,Sabini E,Passannati P,Puleo L,Matrone A,Pontillo-Contillo B,Battaglia V,Mazzeo S,Vitti P,Elisei R

    更新日期：2016-04-01 00:00:00

  • Peroxisome proliferator-activated receptor gamma and BRCA1.

    abstract：:Peroxisome proliferator-activated receptor gamma agonists have been proposed as breast cancer preventives. Individuals who carry a mutated copy of BRCA1, DNA repair-associated gene, are at increased risk for development of breast cancer. Published data in the field suggest there could be interactions between peroxisom...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-18-0449

    authors： Furth PA

    更新日期：2019-02-01 00:00:00

  • Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.

    abstract：:Obesity increases both the risk and mortality associated with many types of cancer including that of the breast. In mice, obesity increases both incidence of spontaneous tumors and burden of transplanted tumors. Our findings identify leptin, an adipose secreted cytokine, in promoting increased mammary tumor burden in ...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-11-0102

    authors： Zheng Q,Dunlap SM,Zhu J,Downs-Kelly E,Rich J,Hursting SD,Berger NA,Reizes O

    更新日期：2011-07-11 00:00:00

  • Uncontrolled insulin secretion from a childhood pancreatic beta-cell adenoma is not due to the functional loss of ATP-sensitive potassium channels.

    abstract：:We report the case of an 8-year-old child who presented with severe hyperinsulinaemic hypoglycaemia due to a pancreatic islet cell adenoma. In vivo, there was no beneficial response to the hyperglycaemia-inducing agent diazoxide and as a consequence the child underwent a subtotal pancreatectomy. In vitro studies of ad...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1677/erc.0.0090221

    authors： Hussain K,Cosgrove KE,Shepherd RM,Chapman JC,Swift SM,Smith VV,Kassem SA,Glaser B,Lindley KJ,Aynsley-Green A,Dunne MJ

    更新日期：2002-12-01 00:00:00

  • SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.

    abstract：:Thyroid cancer is on the rise. Novel approaches are needed to improve the outcome of patients with recurrent and advanced metastatic thyroid cancers. FDA approval of suberoylanilide hydroxamic acid (SAHA; vorinostat), an inhibitor of histone deacetylase, for the treatment of hematological malignancies led to the clini...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-16-0103

    authors： Zhu X,Kim DW,Zhao L,Willingham MC,Cheng SY

    更新日期：2016-07-01 00:00:00

  • Resveratrol and cancer: focus on in vivo evidence.

    abstract：:Resveratrol is a naturally occurring polyphenol that provides a number of anti-aging health benefits including improved metabolism, cardioprotection, and cancer prevention. Much of the work on resveratrol and cancer comes from in vitro studies looking at resveratrol actions on cancer cells and pathways. There are, how...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-13-0171

    authors： Carter LG,D'Orazio JA,Pearson KJ

    更新日期：2014-05-06 00:00:00

  • Genomic classification of benign adrenocortical lesions.

    abstract：:Benign adrenal tumors cover a spectrum of lesions with distinct morphology and steroid secretion. Current classification is empirical. Beyond a few driver mutations, pathophysiology is not well understood. Here, a pangenomic characterization of benign adrenocortical tumors is proposed, aiming at unbiased classificatio...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-20-0128

    authors： Faillot S,Foulonneau T,Néou M,Espiard S,Garinet S,Vaczlavik A,Jouinot A,Rondof W,Septier A,Drougat L,Hécale-Perlemoine K,Ragazzon B,Rizk-Rabin M,Sibony M,Bonnet-Serrano F,Guibourdenche J,Libé R,Groussin L,Dousset B,

    更新日期：2021-01-01 00:00:00

  • The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium.

    abstract：:Cancers of the reproductive tract account for 12% of all malignancies in women. As previous studies have shown that oestrogen metabolites can cause apoptosis, we characterised the effect of oestrogen and oestrogen metabolites on non-cancerous and cancerous human endometrial cells. Herein, we demonstrate that 2-methoxy...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1677/ERC-07-0008

    authors： Kato S,Sadarangani A,Lange S,Villalón M,Brañes J,Brosens JJ,Owen GI,Cuello M

    更新日期：2007-06-01 00:00:00

  • Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.

    abstract：:Tropomyosin receptor kinase (Trk) inhibitors are investigated as a novel targeted therapy in various cancers. We investigated the in vitro effects of the pan-Trk inhibitor GNF-5837 in human neuroendocrine tumor (NET) cells. The human neuroendocrine pancreatic BON1, bronchopulmonary NCI-H727 and ileal GOT1 cell lines w...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-17-0201

    authors： Aristizabal Prada ET,Heinzle V,Knösel T,Nölting S,Spöttl G,Maurer J,Spitzweg C,Angele M,Schmidt N,Beuschlein F,Stalla GK,Blaser R,Kuhn KA,Auernhammer CJ

    更新日期：2018-05-01 00:00:00

  • Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.

    abstract：:The etiology and pathogenesis of renal cell carcinoma (RCC) are only partially understood. Key findings in hereditary RCC, which may be site specific or a component of a syndrome, have contributed to our current understanding. Important heritable syndromes of RCC are those associated with pheochromocytoma, especially ...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-11-0324

    authors： Malinoc A,Sullivan M,Wiech T,Schmid KW,Jilg C,Straeter J,Deger S,Hoffmann MM,Bosse A,Rasp G,Eng C,Neumann HP

    更新日期：2012-05-03 00:00:00

  • The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.

    abstract：:Experimental models of neuroendocrine tumour disease are scarce, and no comprehensive characterisation of existing gastroenteropancreatic neuroendocrine tumour (GEPNET) cell lines has been reported. In this study, we aimed to define the molecular characteristics and therapeutic sensitivity of these cell lines. We ther...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-17-0445

    authors： Hofving T,Arvidsson Y,Almobarak B,Inge L,Pfragner R,Persson M,Stenman G,Kristiansson E,Johanson V,Nilsson O

    更新日期：2018-03-01 00:00:00

  • Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.

    abstract：:Pancreatic neuroendocrine tumors (PanNETs) are rare in von Hippel-Lindau disease (VHL) but cause serious morbidity and mortality. Management guidelines for VHL-PanNETs continue to be based on limited evidence, and survival data to guide surgical management are lacking. We established the European-American-Asian-VHL-Pa...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-18-0100

    authors： Krauss T,Ferrara AM,Links TP,Wellner U,Bancos I,Kvachenyuk A,Villar Gómez de Las Heras K,Yukina MY,Petrov R,Bullivant G,von Duecker L,Jadhav S,Ploeckinger U,Welin S,Schalin-Jäntti C,Gimm O,Pfeifer M,Ngeow J,Hasse-Laza

    更新日期：2018-09-01 00:00:00

  • Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program.

    abstract：:Prostate cancer development and progression is largely dependent on androgen receptor (AR) signaling. AR is a hormone-dependent transcription factor, which binds to thousands of sites throughout the human genome to regulate expression of directly responsive genes, including pro-survival genes that enable tumor cells t...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-19-0181

    authors： Stelloo S,Linder S,Nevedomskaya E,Valle-Encinas E,de Rink I,Wessels LFA,van der Poel H,Bergman AM,Zwart W

    更新日期：2020-02-01 00:00:00

  • Acquired resistance to aromatase inhibitors: where we stand!

    abstract：:Aromatase inhibitors (AIs) are one of the principal therapeutic approaches for estrogen receptor-positive (ER+) breast cancer in postmenopausal women. They block estrogen biosynthesis through aromatase inhibition, thus preventing tumour progression. Besides the therapeutic success of the third-generation AIs, acquired...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-17-0425

    authors： Augusto TV,Correia-da-Silva G,Rodrigues CMP,Teixeira N,Amaral C

    更新日期：2018-05-01 00:00:00

  • Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.

    abstract：:Papillary (PTC) and follicular thyroid carcinoma (FTC) are known as differentiated thyroid carcinoma (DTC). Nevertheless, according to the UICC/AJCC (TNM) classification PTC and FTC are frequently analyzed as one cancer. The aim of this study is to show differences in outcome and specific prognostic factors in an iodi...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1677/erc.0.0110131

    authors： Passler C,Scheuba C,Prager G,Kaczirek K,Kaserer K,Zettinig G,Niederle B

    更新日期：2004-03-01 00:00:00

  • HES5 silencing is an early and recurrent change in prostate tumourigenesis.

    abstract：:Prostate cancer is the most common cancer in men, resulting in over 10 000 deaths/year in the UK. Sequencing and copy number analysis of primary tumours has revealed heterogeneity within tumours and an absence of recurrent founder mutations, consistent with non-genetic disease initiating events. Using methylation prof...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-14-0454

    authors： Massie CE,Spiteri I,Ross-Adams H,Luxton H,Kay J,Whitaker HC,Dunning MJ,Lamb AD,Ramos-Montoya A,Brewer DS,Cooper CS,Eeles R,UK Prostate ICGC Group.,Warren AY,Tavaré S,Neal DE,Lynch AG

    更新日期：2015-04-01 00:00:00

  • HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experience.

    abstract：:Forty years ago, physicians caring for the J-kindred, a 100+ member family with multiple endocrine neoplasia type 2A (MEN2A), hypothesized that early thyroidectomy based on measurement of the biomarker calcitonin could cure patients at risk for development of medullary thyroid carcinoma (MTC). We re-evaluated 22 famil...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-20-0108

    authors： Grubbs EG,Lechan RM,Edeiken-Monroe B,Cote GJ,Trotter C,Tischler AS,Gagel RF

    更新日期：2020-08-01 00:00:00

  • Genetically defined mouse models that mimic natural aspects of human prostate cancer development.

    abstract：:This review is focused on mouse models for prostate cancer that have been designed on the basis of genetic alterations that are frequently found in human prostate cancer. It begins with an analysis of the similarities and differences in the gross and microscopic anatomy of the mouse and human prostate glands, and exte...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1677/erc.0.0110225

    authors： Roy-Burman P,Wu H,Powell WC,Hagenkord J,Cohen MB

    更新日期：2004-06-01 00:00:00

  • Identification of occult tumors by whole-specimen mapping in solitary papillary thyroid carcinoma.

    abstract：:We undertook this study to estimate an accurate incidence and spread patterns of occult papillary thyroid carcinoma (PTC) in patients with a preoperative diagnosis of solitary PTC by using whole-specimen mapping of all specimens after a total thyroidectomy. Enrolled prospectively in this whole-thyroid mapping study ar...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-15-0152

    authors： Park SY,Jung YS,Ryu CH,Lee CY,Lee YJ,Lee EK,Kim SK,Kim TS,Kim TH,Jang J,Park D,Dong SM,Kang JG,Lee JS,Ryu J

    更新日期：2015-08-01 00:00:00

  • MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma.

    abstract：:Type 3 deiodinase (DIO3, D3) is reactivated in human neoplasias. Increased D3 levels in papillary thyroid carcinoma (PTC) have been associated with tumor size and metastatic disease. The objective of this study is to investigate the signaling pathways involved in DIO3 upregulation in PTC. Experiments were performed in...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1530/ERC-15-0162

    authors： Romitti M,Wajner SM,Ceolin L,Ferreira CV,Ribeiro RV,Rohenkohl HC,Weber Sde S,Lopez PL,Fuziwara CS,Kimura ET,Maia AL

    更新日期：2016-03-01 00:00:00

  • Epigenetic regulation by the menin pathway.

    abstract：:There is a trend of increasing prevalence of neuroendocrine tumors (NETs), and the inherited multiple endocrine neoplasia type 1 (MEN1) syndrome serves as a genetic model to investigate how NETs develop and the underlying mechanisms. Menin, encoded by the MEN1 gene, at least partly acts as a scaffold protein by intera...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章,评审

    doi：10.1530/ERC-17-0298

    authors： Feng Z,Ma J,Hua X

    更新日期：2017-10-01 00:00:00

  • Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.

    abstract：:We studied the psychological performance and the quality of life in patients with differentiated thyroid carcinoma, either during treatment with chronic suppressive doses of levothyroxine, or during the withdrawal of levothyroxine needed to perform whole-body scanning with radioactive iodine, with those of appropriate...

    journal_title：Endocrine-related cancer

    pub_type： 杂志文章

    doi：10.1677/erc.0.0100601

    authors： Botella-Carretero JI,Galán JM,Caballero C,Sancho J,Escobar-Morreale HF

    更新日期：2003-12-01 00:00:00